American Herbal Products Association (AHPA) > Resources > Regulations > Government Advocacy

Recent AHPA Advocacy

AHPA Adopts Policy Against Sale of Bulk Caffeine

Recent reports associate serious injury and death with use of pure caffeine purchased by consumers in bulk packaging.

The American Herbal Products Association (AHPA) Board of Trustees on March 4 established a trade requirement that prohibits sale by AHPA members of pure caffeine in bulk form at retail (to consumers).

Whitepaper on DNA barcode testing reveals how misapplication of science led to baseless results

The Capabilities and Limitations of DNA Barcode Testing

A comprehensive analysis of DNA barcode testing on botanical dietary supplements has called conclusions reached by the New York Attorney General’s (NY AG) office in an investigation of four major retailers of botanical supplements, a “…misuse of the technologies” that led to a “…misinterpretation of test results.”

AHPA responds to dozens of media outlets' coverage of New York Attorney General's inadequate testing of herbal supplements

AHPA has responded to more than 20 media outlets' coverage of the New York State Attorney General's supplement investigation to stress that the allegations are based on inadequate and unproven testing of herbal supplement products. The test results are at the core of the Attorney General's misinformed allegations that several major retailers are selling adulterated and/or mislabeled herbal dietary supplements. 

AHPA issues cannabis oversight recommendations for regulators

Oversight framework promotes best practices for cannabis production and distribution from seed to consumption

The American Herbal Products Association (AHPA) has published recommendations for regulators to address issues related to the safe use and responsible commerce of legally-marketed products derived from Cannabis species.

AHPA Calls for Withdrawal of "Hugely Flawed" NDI Notification Guidance in Comments to FDA

AHPA requests FDA to issue new guidance

The American Herbal Products Association (AHPA), in comments filed with the Food and Drug Administration (FDA), called for the agency to withdraw what it called the "hugely flawed" "Draft Guidance for Industry: Dietary Supplements: New Dietary Ingredient Notifications and Related Issues."
RSS
123456

2017 Annual Fund Sponsors

           

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.